Bifendate, the chemical name is 4,4'-dimethoxy-5,6,5',6'-bismethylenedioxybiphenyl-2,2'-dimethyl dicarboxylate, the molecular formula is C20H18O10 It is a commonly used drug for the treatment of viral hepatitis and drug-induced liver injury caused by elevated transaminase. In the past, it was believed to have the pharmacological effects of protecting liver cells and increasing the liver's detoxification function. In particular, its enzyme-lowering effect has obvious effects, low toxicity and small side effects.

Market Analysis and Insights: Global Bifendatatum Market
The global Bifendatatum market was valued at US$ XX in 2020 and will reach US$ XX million by the end of 2027, growing at a CAGR of XX% during 2022-2027.

Global Bifendatatum Scope and Market Size
The global Bifendatatum market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Bifendatatum market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), by Type and by Application for the period 2016-2027.

Segment by Type
Purity>98%
Purity <98%

Segment by Application
Hospital
Laboratory
Others

The Bifendatatum market is analysed and market size information is provided by regions (countries). Segment by Application, the Bifendatatum market is segmented into North America, Europe, China, Japan, Southeast Asia, India and Other Regions.

By Company
Macklin
Yuanye
Herbon International
Yaowei Bio
Xin Wei Ye
HAORONG BIOLOGICAL
Fulu Pharm
Absin
Carnoss
Yyb-Chem
TCI